Clinical Trials · NCT00841113
Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Speciality European Pharma Limited
- Enrollment
- 177
- Start date
- Jan 1999
- Locations
- See registry
- Primary endpoint
- Early castration rates